Amberley Stephens is currently an Associate Principal Scientist at AstraZeneca, where they apply their expertise in molecular biology and neuroscience. Previously, they served as a Senior Research Associate at the University of Cambridge, investigating the role of alpha-synuclein in Parkinson's Disease, and held various research roles within the Molecular Neuroscience and Laser Analytics groups. Amberley earned their PhD in Molecular Microbiology from the University of Nottingham and has a strong educational background, including a Master’s in Microbial Pathogenesis from Imperial College London and a Bachelor’s in Biomedical Sciences from the University of Southampton.
This person is not in the org chart
This person is not in any teams
This person is not in any offices